A Aforeworn
Forewarned is forearmed.
Home › Niches › Healthcare AI Regulation (FDA / ONC) › Change
Medium urgency

FDA Proposes Draft Guidance on Assessing the Credibility of AI Models Used in Drug and Biological Product Submissions - orrick.com

Detected August 21, 2026 · in Healthcare AI Regulation (FDA / ONC)

FDA has proposed draft guidance on assessing the credibility of AI models used in drug and biological product submissions, signaling a shift toward more rigorous validation expectations for AI in regulatory filings.

Aforeworn detected this change in the Healthcare AI Regulation (FDA / ONC) space on August 21, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Medical device companies, health tech startups, and digital health compliance teams developing AI models for drug or biological product submissions. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified in the provided text; check the draft guidance for comment period and effective dates.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Healthcare AI Regulation (FDA / ONC) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

FDA has issued draft guidance outlining expectations for evaluating the credibility of AI models in regulatory submissions, which may affect how AI models are validated and documented.

Who it affects

Medical device companies, health tech startups, and digital health compliance teams developing AI models for drug or biological product submissions.

What you must do

Review the draft guidance to understand the proposed credibility assessment framework and prepare to align AI model validation practices accordingly.

Deadline

Not specified in the provided text; check the draft guidance for comment period and effective dates.

Source: https://news.google.com/rss/articles/CBMiqAFBVV95cUxPd2dLOENBeHVoakM3a2xYT2NRY1hLV1AyMERJTzdMb2F3c2tFTk8yT1ZNWm9ieE9DSGRiZXhvSHR6MHYxSkt6djVwaWRmSkRqdy1qeUxRMlM2UGJ1SzFnckwwT0ZvSm8xeEVaRWRWTEkyeTMxaXhwTmgwTEVNdzc4ekVCRFJzejZ0Wk5SQ1c5RDBET25SampxWC1aTXhqUHJ6MVA0c1Y0U0s?oc=5

Never miss a change like this again

Aforeworn watches Healthcare AI Regulation (FDA / ONC) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Healthcare AI Regulation (FDA / ONC)